Clinical

This channel newsfeed includes clinical content on treating patients or the clinical implications in a variety of cardiac subspecialties and disease states. The channel includes news on cardiac surgery, interventional cardiology, heart failure, electrophysiology, hypertension, structural heart disease, use of pharmaceuticals, and COVID-19.

HHS, RFK sued by medical associations over COVID policy shift
Multiple professional groups, including the American Academy of Pediatrics and the American College of Physicians, challenge recent policy changes to vaccine recommendations for COVID-19, which end routine inoculations for minors and pregnant women.
New TAVR valve from MiRus linked to positive early outcomes
The Siegel TAVR valve includes no nickel or cobalt. In fact, its frame was built using special alloys specifically developed by MiRus.
EHR-driven PCI risk assessments could make a world of difference
Researchers with Mayo Clinic have shown that EHR-driven risk assessments could go a long way toward improving care for PCI patients.
FDA expands approval of Boston Scientific’s Farapulse PFA system
The FDA's 2024 approval of the Farapulse system covered patients with paroxysmal atrial fibrillation. Now, however, the technology is officially approved for patients with more persistent symptoms.
No biopsy required: Blood test could spot signs of rejection in heart transplant recipients
It may not always be necessary to subject heart transplant patients to one biopsy after another.

The study's authors tracked 450 patients with uncontrolled high blood pressure.

Cardiologists may way want to pay close attention to a new study published in the American Journal of Cardiology.

In total, nine organizations will receive funding as part of the institute's Rapid Acceleration of Diagnostics initiative or RADx.

The team's analysis also examines why blood-thinning medications aren't effectively preventing the clots.

ACC.21 will now take place May 15-17, 2021, in Atlanta.

Researchers tracked more than 3,300 older patients for three years, performing clinical assessments every six months.

The patient-specific models were designed to help clinicians prepare for transcatheter aortic valve replacement (TAVR) procedures.

Researchers detailed a method that improves patient safety and leads to significant cost savings.